Oncology Pharmacogenomics I: Solid Tumors 2010

Описание к видео Oncology Pharmacogenomics I: Solid Tumors 2010

Speaker: John M. Valgus, Pharm.D., BCOP

Presentation Outline:
◾Irinotecan and UGT1A1
--Role in UGT1A1 in metabolism of irinotecan
--Association of UGT1A1 genotype and irinotecan

◾EGFR Therapy and KRAS
--Overview of EGFR pharmacology and role of KRAS
--Impact of KRAS on response to EFGR therapy
--Practice recommendations

◾Tamoxifen and CYP2D6
--Role of CYP2D6 in metabolism of tamoxifen
--Overview of clinical data evaluating the impact of CYP2D6 on tamoxifen clinical outcomes
--Practice recommendations

Комментарии

Информация по комментариям в разработке